Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Long-term results confirm clinical research led by radiation oncologists at the Princess Margaret that adding radiotherapy to the treatment of men who have high-risk prostate cancer improves survival.
These results were published Feb. 17 in the
Journal of Clinical Oncology.
Adding radiotherapy to long-term hormone therapy halved the risk of men dying from prostate cancer within eight years. These results confirm the findings of an interim analysis that was published in the
Lancet in 2011, says Dr. Padraig Warde, principal investigator.
"In 2011, based on the interim findings, we concluded that adding radiation to the treatment plan should become part of the standard therapy," says Dr. Warde. "It's excellent to know that the benefit of combining radiation and hormone therapy is maintained over the long-term. This provides real hope – and quality of life – for men fighting this disease."
Between 1995 and 2005, the clinical trial recruited 1,205 patients with locally-advanced prostate cancer that had grown outside the surface of the prostate but had not spread further. Half were treated with hormone therapy and the other half were treated with a combination of hormone therapy and radiotherapy.